IRIS Institutional Research Information System - OPENBS Open Archive UniBS

ANDREOLI, Laura
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.243
EU - Europa 5.882
AS - Asia 1.594
AF - Africa 23
SA - Sud America 20
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 15
AN - Antartide 1
Totale 16.794
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.215
DE - Germania 1.996
UA - Ucraina 1.170
CN - Cina 1.006
PL - Polonia 726
IT - Italia 533
HK - Hong Kong 428
RU - Federazione Russa 336
FI - Finlandia 313
GB - Regno Unito 239
IE - Irlanda 226
FR - Francia 176
SE - Svezia 71
IN - India 43
VN - Vietnam 26
CA - Canada 23
TR - Turchia 23
AU - Australia 16
EU - Europa 15
NL - Olanda 15
BE - Belgio 13
GR - Grecia 12
BR - Brasile 11
ES - Italia 11
SG - Singapore 11
EG - Egitto 10
JP - Giappone 7
MK - Macedonia 7
TH - Thailandia 7
CH - Svizzera 6
RS - Serbia 6
AE - Emirati Arabi Uniti 5
AR - Argentina 5
KR - Corea 5
RO - Romania 5
HU - Ungheria 4
IQ - Iraq 4
PH - Filippine 4
BG - Bulgaria 3
DK - Danimarca 3
GE - Georgia 3
IR - Iran 3
MY - Malesia 3
PT - Portogallo 3
AM - Armenia 2
AT - Austria 2
CI - Costa d'Avorio 2
DZ - Algeria 2
ID - Indonesia 2
JM - Giamaica 2
KZ - Kazakistan 2
LY - Libia 2
MA - Marocco 2
MU - Mauritius 2
SA - Arabia Saudita 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BD - Bangladesh 1
BO - Bolivia 1
BY - Bielorussia 1
CL - Cile 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
GS - Georgia del Sud e Isole Sandwich Australi 1
GT - Guatemala 1
IL - Israele 1
KW - Kuwait 1
LB - Libano 1
LU - Lussemburgo 1
MX - Messico 1
NG - Nigeria 1
NP - Nepal 1
OM - Oman 1
PE - Perù 1
PK - Pakistan 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
UG - Uganda 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 16.794
Salva come PNG Salva come JPEG
Città #
Fairfield 1.489
Woodbridge 1.174
Jacksonville 828
Houston 809
Warsaw 723
Ashburn 702
Seattle 561
Cambridge 544
Wilmington 508
Ann Arbor 491
Princeton 439
Hong Kong 424
Chandler 341
New York 271
Dublin 226
Nanjing 223
Helsinki 204
Beijing 180
Nürnberg 102
Brescia 99
Nanchang 99
San Diego 96
Des Moines 89
Changsha 73
Shenyang 66
Hebei 65
Lancaster 58
Milan 52
Shanghai 49
Jinan 39
London 35
Dearborn 32
Jiaxing 32
Bergamo 26
Tianjin 26
Dong Ket 24
Verona 24
Hangzhou 23
San Francisco 22
Kunming 20
Zhengzhou 19
Toronto 18
Boardman 16
Taizhou 16
Haikou 14
Lanzhou 14
Los Angeles 13
Brussels 12
Ningbo 12
Rome 11
Orange 10
Augusta 9
Hanover 9
Melbourne 9
Pune 9
Kocaeli 8
Guangzhou 7
Norwalk 7
Siena 7
Chicago 6
Detroit 6
Hounslow 6
Kilburn 6
Lappeenranta 6
Redwood City 6
San Mateo 6
Tokyo 6
Acton 5
Chiswick 5
Falkenstein 5
Fuzhou 5
Strasbourg 5
Taiyuan 5
Alexandria 4
Cologne 4
Gunzenhausen 4
Napoli 4
Parabiago 4
Phoenix 4
Prescot 4
Redmond 4
Rende 4
Sutton Coldfield 4
Sydney 4
Turin 4
Walnut 4
Washington 4
Amsterdam 3
Arbil 3
Arcos De La Frontera 3
Ardabil 3
Canberra 3
Changchun 3
Dallas 3
Duncan 3
Frankfurt am Main 3
Genova 3
Leawood 3
Manerbio 3
Mariano Comense 3
Totale 11.681
Salva come PNG Salva come JPEG
Nome #
Role of guanylate binding protein-1 in vascular defects associated with chronic inflammatory diseases. 254
EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome 240
9A.07: CARDIOVASCULAR TARGET ORGAN DAMAGE IN PREMENOPAUSAL SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS AND IN CONTROLS. ARE THERE ANY DIFFERENCES? 235
The Pathogenicity of Anti-β2GP1-IgG Autoantibodies Depends on Fc Glycosylation 201
Long-term outcome of children of rheumatic disease patients 170
SINDROME DA ANTICORPI ANTIFOSFOLIPIDI E LESIONI PUNTIFORMI DELLA SOSTANZA BIANCA ALLA RISONANZA MAGNETICA. QUAL E' IL LORO SIGNIFICATO? VALUTAZIONE DI 169 PAZIENTI CON MANIFESTAZIONI NEUROLOGICHE 159
Aicardi-Goutieres syndrome, a rare neurological disease in children: a new autoimmune disorder? 159
Sine causa tetraparesis: A pilot study on its possible relationship with interferon signature analysis and Aicardi Goutières syndrome related genes analysis 152
Antirheumatic drugs and reproduction in women and men with chronic arthritis. 150
14th International Congress on Antiphospholipid Antibodies Task Force report on obstetric antiphospholipid syndrome 146
Trichostatin A blocks type I interferon production by activated plasmacytoid dendritic cells. 145
Typing TREX1 Gene In Patients With Systemic Lupus Erythematosus. 139
14th International Congress on Antiphospholipid Antibodies Task Force. Report on antiphospholipid syndrome laboratory diagnostics and trends 139
The role of second trimester uterine artery Doppler in pregnancies with systemic lupus erythematosus 131
Pregnancy implications for systemic lupus erythematosus and the antiphospholipid syndrome 127
Patients with longstanding primary antiphospholipid syndrome: retrospective analysis of organ damage and mortality 126
Anti-cardiolipin and anti-beta2-glycoprotein I antibodies: performance of new commercial ELISA kits. 125
Anti-IFI16 antibodies and their relation to disease characteristics in systemic lupus erythematosus. 125
A 24-month prospective study on the efficacy and safety of two different monthly regimens of vitamin D supplementation in pre-menopausal women with systemic lupus erythematosus 123
A comprehensive review of the clinical approach to pregnancy and systemic lupus erythematosus 123
Autoantibodies against galectin-2 peptides as biomarkers for the antiphospholipid syndrome. 122
Antiphospholipid antibodies mediate autoimmunity against dying cells. 122
Inflammatory molecules: A target for treatment of systemic autoimmune diseases. 121
Children born to SLE and APS mothers 121
Anti-phospholipid antibodies 119
Effector T-cells are expanded in systemic lupus erythematosus patients with high disease activity and damage indexes 118
First Report of the Italian Registry on Immune-Mediated Congenital Heart Block (Lu.Ne Registry) 118
Management of thrombotic and obstetric antiphospholipid syndrome: A systematic literature review informing the EULAR recommendations for the management of antiphospholipid syndrome in adults 118
The effects of lupus and antiphospholipid antibody syndrome on foetal outcomes 116
Macrophage activation syndrome in adult systemic lupus erythematosus: Report of seven adult cases from a single Italian rheumatology center 116
25 years of the antiphospholipid syndrome: lights and shadows on the primary prophylaxis of asymptomatic patients with confirmed positivity of antiphospholipid antibodies. 115
Autoantibodies against galectins are associated with antiphospholipid syndrome in patients with systemic lupus erythematosus. 114
Management of recurrent thrombosis in antiphospholipid syndrome 114
Organ damage accrual and distribution in systemic lupus erythematosus patients followed-up for more than 10 years 112
Antinucleosome antibodies in primary antiphospholipid syndrome: a hint at systemic autoimmunity? 111
Much more than thrombosis and pregnancy loss: the antiphospholipid syndrome as a 'systemic disease'. 111
Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome 111
Pregnancy in autoimmune rheumatic diseases: the importance of counselling for old and new challenges. 110
Beyond the "syndrome": antiphospholipid antibodies as risk factors. 110
Autoantibodies' titre modulation by anti-BlyS treatment in systemic lupus erythematosus. 109
State of the art: Reproduction and pregnancy in rheumatic diseases. 108
Phenotype modifications of T-cells and their shift toward a Th2 response in patients with systemic lupus erythematosus supplemented with different monthly regimens of vitamin D 108
APS ACTION--AntiPhospholipid Syndrome Alliance For Clinical Trials and InternatiOnal Networking. 107
Association Between Changes in BLyS Levels and the Composition of B and T Cell Compartments in Patients With Refractory Systemic Lupus Erythematosus Treated With Belimumab 106
Are the current attempts at standardization of antiphospholipid antibodies still useful? Emerging technologies signal a shift in direction. 105
Long-term neurodevelopmental outcome of children born to prospectively followed pregnancies of women with systemic lupus erythematosus and/or antiphospholipid syndrome 105
Neonatal effects of maternal antiphospholipid syndrome. 104
Antiphospholipid antibody profile: implications for the evaluation and management of patients. 104
High intensity anticoagulation in the prevention of the recurrence of arterial thrombosis in antiphospholipid syndrome: 'PROS' and 'CONS'. 104
Exploring Autoimmunity in a Cohort of Children with Genetically Confirmed Aicardi–Goutières Syndrome 104
Estimated frequency of antiphospholipid antibodies in patients with pregnancy morbidity, stroke, myocardial infarction, and deep vein thrombosis: a critical review of the literature. 104
Longterm outcome of patients with primary antiphospholipid syndrome: A retrospective multicenter study 104
Development of automated assays for anticardiolipin antibodies determination: addressing antigen and standardization issues. 103
Involvement of renal tubular Toll-like receptor 9 in the development of tubulointerstitial injury in systemic lupus. 103
Systemic vasculitis and pregnancy: a multicenter study on maternal and neonatal outcome of 65 prospectively followed pregnancies 102
Pregnancy in patients with autoimmune disease: A reality in 2016 102
Validity of the rheumatoid arthritis impact of disease (RAID) score and definition of cut-off points for disease activity states in a population-based European cohort of patients with rheumatoid arthritis 101
Primary antiphospholipid syndrome evolving into systemic lupus erythematosus: may antinucleosome antibodies be predictive? 100
European multicentre pilot survey to assess vitamin D status in rheumatoid arthritis patients and early development of a new Patient Reported Outcome questionnaire (D-PRO) 100
Risk factors for adverse maternal and fetal outcomes in women with confirmed aPL positivity: Results from a multicenter study of 283 pregnancies 100
COVID-19 in patients with rheumatic diseases in northern Italy: a single-centre observational and case–control study 100
Primary anti-phospholipid syndrome: any role for serum complement levels in predicting pregnancy complications? 99
Low levels of vitamin D are common in primary antiphospholipid syndrome with thrombotic disease. 99
Predictors of maternal and fetal complications in SLE patients: a prospective study 99
Are the autoimmune/inflammatory syndrome induced by adjuvants (ASIA) and the undifferentiated connective tissue disease (UCTD) related to each other? A case-control study of environmental exposures 98
The Efficacy and Safety of Cyclosporin A in Pregnant Patients with Systemic Autoimmune Diseases 98
Cardiovascular target organ damage in premenopausal systemic lupus erythematosus patients and in controls: Are there any differences? 98
The 2016 classification criteria for primary Sjogren's syndrome: What's new? 98
Long-term use of hydroxychloroquine reduces antiphospholipid antibodies levels in patients with primary antiphospholipid syndrome 97
PROSPECTIVELY FOLLOWED PREGNANCIES IN PATIENTS WITH SYSTEMIC VASCULITIS: STILL MANY PROBLEMS ON BOTH FOETAL AND MATERNAL SIDE 96
METODICHE AUTOMATIZZATE PER ANTICORPI ANTINUCLEO (ANA): E' POSSIBILE SOSTITUIRE L'IMMUNOFLUORESCENZA INDIRETTA? 94
Exosome-delivered microRNAs promote IFN-α secretion by human plasmacytoid DCs via TLR7 94
Anti-phospholipid IgG antibodies detected by line immunoassay differentiate patients with anti-phospholipid syndrome and other autoimmune diseases 93
DIAGNOSTIC PERFORMANCE OF TWO AUTOMATED ASSAY PANELS FOR ANTICARDIOLIPIN AND ANTI-BETA2GLYCOPROTEIN I ANTIBODIES IN THE LABORATORY DIAGNOSIS OF ANTIPHOSPHOLIPID SYNDROME 91
Anti-inflammatory action of colchicine in hospitalised patients with COVID-19. Response to: 'Colchicine treatment in community healthcare setting to prevent severe COVID-19' by Della-Torre et al 91
EFFICACY AND SAFETY OF CYCLOSPORINE-A DURING PREGNANCY IN AUTOIMMUNE DISEASES 90
DOMAIN 1 IS THE MAIN SPECIFICITY OF ANTI-BETA2GPI ANTIBODIES IN SYSTEMIC AUTOIMMUNE DISEASES 89
Vitamin D and antiphospholipid syndrome. 88
ANTI-BETA2 GLYCOPROTEIN I-DOMAIN 1 AUTOANTIBODIES: COMPARISON BETWEEN TWO METHODS OF DETECTION 88
Pathophysiological role and therapeutic implications of vitamin d in autoimmunity: Focus on chronic autoimmune diseases 88
The efficacy of hydroxychloroquine for obstetrical outcome in anti-phospholipid syndrome: Data from a European multicenter retrospective study 87
Clinical predictors of response and discontinuation of belimumab in patients with systemic lupus erythematosus in real life setting. Results of a large, multicentric, nationwide study 87
Clinical significance of IgA anti-cardiolipin and IgA anti-β2glycoprotein I antibodies. 86
Lymphopenia as a risk factor for neurologic involvement and organ damage accrual in patients with systemic lupus erythematosus: A multi-center observational study 85
Long-term outcome of children born from mothers with autoimmune diseases 85
Refractory obstetrical antiphospholipid syndrome: Features, treatment and outcome in a European multicenter retrospective study 84
IL COMPLEMENTO NELLA GRAVIDANZA DI DONNE AFFETTE DA SINDROME DA ANTICORPI ANTIFOSFOLIPIDI PRIMARIA 83
Update on Antiphospholipid Syndrome: Ten Topics in 2017 83
The estimated frequency of Antiphospholipid antibodies in young adults with cerebrovascular events: A systematic review 82
I polimorfismi della metilentetraidrofolatoreduttasi (MTHFR) nel trattamento con methotrexate di pazienti con artrite reumatoide. Revisione della letteratura ed esperienza personale. 81
An EULAR study group pilot study on reliability of simple capillaroscopic definitions to describe capillary morphology in rheumatic diseases 81
WINTER LUPUS FLARES ARE ASSOCIATED WITH LOWER VITAMIN D LEVELS IN A RETROSPECTIVE LONGITUDINAL STUDY OF ITALIAN PATIENTS 80
Recurrent thrombosis in patients with antiphospholipid antibodies and arterial thrombosis on antithrombotic therapy 80
DECREASED TITER OF ANTI-CCP ANTIBODIES AND RHEUMATOID FACTOR AND REDUCTION OF POSTSWITCH MEMORY B CELLS AFTER ABATACEPT TREATMENT FOR RHEUMATOID ARTHRITIS 79
The association between antiphospholipid antibodies and pregnancy morbidity, stroke, myocardial infarction, and deep vein thrombosis: A critical review of the literature 79
The antiphospholipid syndrome in patients with systemic lupus erythematosus 78
LONG TERM OUTCOME IN CHILDREN BORN TO MOTHERS WITH SYSTEMIC LUPUS ERYTEMATOSUS AND ANTIPHOSPHOLIPID SYNDROME 77
THE PREVALENCE AND INCIDENCE OF SYSTEMIC LUPUS ERYTHEMATOSUS IN NORTHERN ITALY: AN EPIDEMIOLOGICAL STUDY CONDUCTED WITH THE “CAPTURE-RECAPTURE” METHODOLOGY 77
Domain 1 Is The Main Specificity Of Anti-b2glycoprotein I Antibodies In Systemic Autoimmune Diseases. 77
A PROSPECTIVE STUDY IN PREMENOPAUSAL WOMEN WITH SYSTEMIC LUPUS ERYTHEMATOSUS SUPPLEMENTED WITH TWO DIFFERENT REGIMES OF VITAMIN D: EFFICACY AND SAFETY AT SIX MONTHS OF FOLLOW-UP 77
Totale 11.067
Salva come PNG Salva come JPEG
Categoria #
all - tutte 76.016
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 76.016
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019726 0 0 0 0 0 0 0 0 0 0 376 350
2019/20203.615 530 130 149 411 214 383 313 395 272 454 130 234
2020/20213.598 51 409 248 527 182 422 113 354 331 473 312 176
2021/20221.763 114 280 54 102 20 102 57 132 103 206 172 421
2022/20231.274 248 16 32 56 123 373 5 107 174 4 64 72
2023/20241.509 108 64 144 157 66 345 56 78 454 33 4 0
Totale 17.189